Skip to main content
. 2013 Jul 11;7(7):e2312. doi: 10.1371/journal.pntd.0002312

Table 2. Persons treated in the NTD programme1.

Village Group (age range in years) Total # of Eligible* Persons Treated, Treatment Register Total # of Eligible* Persons Listed Treatment Register Total # of Eligible* Persons Listed VHRB†† Proportion Treated with Treatment Register Denominator Proportion Treated with VHRB†† Denominator
Bugobi A Women (18–49) 71 78 119 71/78 (91%) 71/119 (60%)
Men (18–49) 45 58 202 45/58 (76%) 45/202 (22%)
Buyelo B Women (18–49) 68 89 157 68/89 (76%) 68/157 (43%)
Men (18–49) 64 88 114 64/88 (73%) 64/114 (56%)
Itamia Meeru Women (18–49) 66 69 137 66/69 (96%) 66/137 (48%)
Men (18–49) 46 52 124 46/52 (88%) 46/124 (37%)
1

Total persons treated according to NTD Control Programme treatment registers and Village Household Register Books (using available data sources). Of the eight villages in which the study was conducted, only the above three villages had a treatment register that appeared complete enough to use for analysis.

*

Persons eligible for treatment include persons ages five and older who are not seriously ill (for praziquantel), persons ages five and older who are not seriously ill, pregnant or breastfeeding (for ivermectin and zithromax), or persons ages 1 and older who are not seriously ill, including pregnant women in their second or third trimester (for albendazole).

Treatment registers are kept by the CMDs in each community and are used to register participants who are eligible to participate in the NTD programme.

††

VHRB is Village Household Register Book which is kept by the Chairman of the Local Council (the Village Level government structure) in each village, and registers the number of persons living in each village (including births, deaths, new migrants, etc.) including age and gender.